Introduction {#sec1-1}
============

Decompressive craniectomy (DC) is frequently performed for increased intracranial pressure (ICP) refractory to medical treatment. In surviving patients, auto- or heterologous bone flaps are usually replanted several weeks or months after stabilization of their physical condition. Due to the large defect area and, therefore, possibly altered cerebral haemodynamics, even a mild brain swelling may severely complicate bone flap implantation/replantation from a surgical viewpoint.

In both clinical and experimental studies, various effects of propofol-based and inhalational (volatile) anesthetics on intracranial pressure (ICP), cerebral blood flow (CBF), and brain volume have been documented.\[[@ref1][@ref2][@ref3][@ref4][@ref5]\] However, published data are not congruent and insufficient for a clear decision regarding which anesthesia technique is best. Therefore, the optimal anesthetic drug for cranial procedures is still controversial due to the potential side effects, e.g., impairment of surgical conditions\[[@ref6][@ref7]\] or higher blood loss caused by altered cerebral perfusion.\[[@ref8]\] As some recent literature showed at least a slightly increased risk for brain swelling during the use of volatile anesthetics,\[[@ref3]\] propofol is still considered the agent of choice in many neuroanesthesia centres.\[[@ref3][@ref5]\]

Regarding the shortage of available literature and its focus on craniotomies for brain tumors, we concentrated on a patient cohort, which is usually in a significantly impaired clinical condition and at a high risk for peri- and postoperative complications. The aim of the present study was to analyze the number and rate of complications when using volatile versus intravenous anesthesia drugs as well as their feasibility in patients undergoing cranioplasty.

Material and Methods {#sec1-2}
====================

Patient identification {#sec2-1}
----------------------

In a retrospective analysis, all patients undergoing cranioplasty in our institution between December 2010 and January 2014 were identified using a computerized database. Patients with preoperative (lumbar drain) or permanent cerebrospinal fluid (CSV) diversion (ventriculoperitoneal shunt) were excluded. Because data analysis was performed anonymously, the ethical board of the medical faculty of Cologne waived patient consent and a vote was not required.

Indication for cranioplasty and surgical procedure {#sec2-2}
--------------------------------------------------

Reimplantational surgery is usually done when the brain is completely quiescent. Therefore, surgery was indicated in all patients with radiological and clinical evidence of no brain swelling. The surgical protocol aimed at reimplantation of the autologous or custom-made bone flap. Therefore, the prior incision was re-opened, and a plane between duraplasty and scalp as well as the temporal muscle were dissected. The bone flap was fixated using bone plates or bone clamps. In case of unexpected intraoperative brain swelling, an ultrasound-guided ventriculostomy was performed.

During the period of interest, the choice of the drugs used for maintaining anesthesia (volatile or intravenous anesthesia) was left to the anesthesiologist.

Anesthesia induction was standardized with intravenous propofol in all patients.

Data retrieval from patient charts {#sec2-3}
----------------------------------

The following parameters were retrieved from medical charts.

Baseline data \[age, gender, time between primary surgery and cranioplasty, comorbidity, smoking status, body mass index (BMI), labs (standard hematological, serum chemistry, coagulation parameters)\]Surgery-associated parameters: preoperative \[pre-op computed tomography (CT) scan\] intraoperative \[bone flap fit, ventriculostomy and amount of cerebrospinal fluid (CSF) drained\], postoperative (procedural complications)Anesthesiology data \[anesthetic agents (propofol, volatile drugs), anesthesia depth (MAC in inhalational anesthesia), infusion volume (colloids, crystalloids), fluid balance, PEEP, P~max~, PetO~2~\].

Preoperative brain level in the cerebral CT was graded in a three-step scale: below (A), at (B), or exceeding (C) the bone level at least at one site. Intraoperative fitting according to the surgical records was graded dichotomized in (A) no or slight resistance but able to place flap and (B) high resistance with an inability to place the flap or making intraoperative ventriculostomy necessary. The primary outcome parameter was brain swelling.

Prognostic factors for poor bone flap fit {#sec2-4}
-----------------------------------------

Poor flap fit was defined by the necessity of unplanned ventriculostomy during surgery and the surgeon\'s assessment of the intraoperative condition.

Statistical analysis {#sec2-5}
--------------------

Equal distribution was assessed using Levene\'s test. Categorical variables were analyzed using the Chi-square test. Normally distributed continuous variables were analyzed using the *t*-test, otherwise Mann--Whitney-U test was used. A *P* value of \<0.05 was considered statistically significant.

Results {#sec1-3}
=======

Patient baseline characteristics {#sec2-6}
--------------------------------

A total of 101 consecutive patients with cranioplasty were identified. Twenty-three patients were excluded due to a permanent CSF diversion. Thus, 78 patients were included in the study.

In 75 patients (96.2%), a hemicraniectomy, and in three (3.8%) a bifrontal craniectomy was performed. The demographic data and preoperative charateristics are given in [Table 1](#T1){ref-type="table"}. The intraoperative data are summarized in [Table 2](#T2){ref-type="table"}.

###### 

Comparison of both groups
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###### 

Intraoperative conditions
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General anesthesia was maintained using volatile anesthetics in 22 (28.2%) and propofol in 56 (71.8%) patients. No patient received a combination of propofol and inhalational anesthesia gas. Among anesthesia parameters, no significant differences between the groups were found except a higher PEEP in the propofol group (5.3 vs. 4.9 mmHg, *P* = 0.022) \[[Table 2](#T2){ref-type="table"}\].

The rate of impaired bone flap placement was not significantly different between the groups; neither was postoperative complication rate.

In univariate analysis, no anesthesia-related parameter showed significant differences concerning bone flap placement. Reason for decompressive craniotomy, time between decompressive craniotomy and cranioplasty and extent of decompressive craniotomy showed no significant difference \[[Table 2](#T2){ref-type="table"}\].

Complications occurred in 14 (17.7%) patients, of which 12 were surgical complications. One patient developed pulmonary embolism after surgery, and one postoperative sepsis occurred. Most common surgical complication was postoperative wound and bone flap infection (10/14). No anesthesia-related complications were found \[[Table 3](#T3){ref-type="table"}\].

###### 

Postoperative complications

![](JOACP-34-172-g003)

Discussion {#sec1-4}
==========

The ongoing discussion regarding the optimal drug for anesthesia maintenance is frequently ruled by nonobjective arguments, e.g., neurosurgeons categorically rejecting volatile anesthetics due to possible brain swelling. However, sound data (e.g., randomized controlled trials, RCT) covering this topic are still insufficient.\[[@ref2][@ref3]\] Our study, therefore, aims to elucidate the impact of volatile vs. propofol-based anesthesia in a well-defined neurosurgical cohort prone to complications by intraoperative brain swelling.

Patients after decompressive craniectomy show large bony defects with brain tissue covered only by dura and skin tissues. Cranioplasty is indicated after regression of brain swelling documented by CT. Frequently, involution of the defect may result in brain surface deformity with posterior parts of parenchyma exceeding bony level.

Due to large bone defects, an increase of brain tissue volume, may easily change local conditions and aggravate bone flap positioning. Therefore, intraoperative ventriculostomy may be necessary. Both volatiles and propofol may influence CBF, cerebral metabolism, and ICP.\[[@ref2][@ref3][@ref5][@ref9]\]

Traditionally, volatiles are believed to influence operative conditions negatively by elevating CBF and thus ICP. As a recent meta-analysis also suggested an advantage of propofol vs. volatiles due to a reduced ICP and CBF, propofol still is the agent of choice among many neuroanesthesiologists. However, valid data concerning the influence of volatiles on surgical conditions during intracranial surgery are scarce.\[[@ref2]\]

In our cohort, the choice of anesthetic drug was left to the anesthesiologist. This was influenced by their personal experience and temporary trends within the clinic. In contrast to some published results suggesting a negative impact of volatiles,\[[@ref2]\] no impact on intraoperative bone flap fitting could be observed in our series. The higher positive end expiratory positive pressure in the propofol group, being the only significantly differing parameter, did not influence surgical course.

Our findings have to be discussed in the context of the narrowly defined patient cohort; little is known about hemodynamics in infarcted or traumatically damaged brain tissue after the acute phase. However, it can be presumed that there is still a remaining (or re-established) autoregulation in these patients with an even increased CBF due to decompressed status. Thus, these patients could be considered more sensitive to regulatory changes by anesthetic drugs, and therefore, should represent an ideal patient cohort. Noteworthy, the underlying reason for DC showed no significant influence.

The effect of volatiles on CBF have been examined in both clinical and experimental conditions. A relevant vasodilatation during inhalational anesthesia is a frequently postulated phenomenon,\[[@ref2]\] which can be counteracted by mild hyperventilation during anesthesia maintenance.\[[@ref10]\] Thus, a potential risk of using volatiles depends largely on the experience of the anesthesiologist.

The present study certainly has several limitations. The study was performed in a retrospective manner from originally clinical data. Because the decision of choice of drug was made by the anesthesiologist it cannot be clearly ruled out that additional clinical factors influenced decision making which cannot be identified retrospectively. In other words, there may be a bias for using propofol in patients with ICP problems and volatile agents in noncomplex patients. Furthermore, the number of patients in the present study is limited, even though analyzing four consecutive years in a large neurosurgical centre.

Conclusion {#sec1-5}
==========

In conclusion, our data indicate that both volatiles and propofol-based anesthesia may be feasible in neurosurgical patients for skull bone replantation. However, since the number of patients is low and the study has a retrospective design, further randomized studies should be conducted in the future.
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